title: Primary central nervous system lymphoma in a renal transplant recipient with Bardet-Biedl syndrome.
abstract: Bardet-Biedl syndrome (BBS) is a rare autosomal recessive disorder. End-stage renal failure has been reported as the most frequent cause of death in this disorder. There are few reports of kidney transplantation in these patients. Renal transplant patients are known to be at increased risk for the development of malignancies. Although a few patients with BBS have been described to develop malignant disease, there was no previous association with lymphoma. We report a 20-year-old patient in whom primary central nervous system lymphoma was diagnosed 20 months after renal transplantation.
authors.affiliation: Department of Nephrology, Uludağ University Medical School, Bursa, Turkey. alpersoy@uludag.edu.tr
authors.forename: A
authors.initials: A
authors.lastname: Ersoy
authors.forename: S
authors.initials: S
authors.lastname: Kahvecioglu
authors.forename: A
authors.initials: A
authors.lastname: Bekar
authors.forename: S
authors.initials: S
authors.lastname: Aker
authors.forename: I
authors.initials: I
authors.lastname: Akdag
authors.forename: K
authors.initials: K
authors.lastname: Dilek
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D020788:Bardet-Biedl Syndrome / Q000150:complications*; D016543:Central Nervous System Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy; D003131:Combined Modality Therapy; D003404:Creatinine / Q000097:blood; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation; D008223:Lymphoma / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy; D008727:Methotrexate / Q000627:therapeutic use; D011183:Postoperative Complications / Q000175:diagnosis
chemical_list: D000970:Antineoplastic Agents; D003404:Creatinine; D008727:Methotrexate